Trial of Bone-marrow Derived Mesenchymal Stromal Cells (MSC) for New Onset Chronic Lung Allograft Dysfunction

NCT02709343 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

64

Enrollment

OTHER

Sponsor class

Conditions

Chronic Lung Allograft Dysfunction (CLAD)

Interventions

DRUG: Bone-marrow derived MSCs
DRUG: Placebo

Sponsor

The University of Queensland

Collaborators

[object Object]
[object Object]